Article info
Hepatology
Original article
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- Correspondence to Professor H L A Janssen, University of Toronto & Erasmus University Rotterdam, University Health Network, 399 Bathurst Street, 6B FP, Room 164, Toronto, Ontario, Canada M5T 2S8; harry.janssen{at}uhn.ca
Citation
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Publication history
- Received February 13, 2014
- Revised May 29, 2014
- Accepted May 29, 2014
- First published July 10, 2014.
Online issue publication
July 09, 2015
Article Versions
- Previous version (10 July 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions